BridgeMD
Compares treatment options for Chronic Pelvic Pain
Official title Effect of Radiofrequency in Women With Chronic Pelvic Pain With an Associated Myofascial Syndrome Versus Myofascial Therapy and no Treatment
ClinicalTrials.gov ID: NCT06908200
What this study is testing
- What it's testing
- A randomised clinical trial is being conducted in the Gynecology Department of the Hospital Clinic de Barcelona in women presenting chronic pelvic pain syndrome due to a myofascial cause which is over a 4 score in the VAS scale and not related to an obstetric injury. This study presents 4 groups; two groups receive 8 radiofrequency sessions, one group receives 8 sessions of myofascial release therapy (MRT) and the last group receives no treatment at all (NT).
- Time commitment: about 8 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- included women who were:
- At least 18 years of age
- Presenting with pelvic pain persisting for at least 6 months
- Diagnosed with myofascial syndrome of the pelvic floor muscles (PFM) by a specialist based on physical assessment
- Presenting with pelvic pain intensity greater than 4 on the Visual Analog Scale (VAS) in the last 3 months
You likely can't join if
- included the following:
- Patients who were pregnant
- Postpartum patients who had given birth within the last year
- Patients with a history of vulvovaginal pathology
- Contraindications for the use of radiofrequency: metal implants or active infection
- Patients with a history of pelvic cancer, including those who had undergone chemotherapy, radiotherapy, and/or brachytherapy.
See the full eligibility criteria
- included women who were:
- At least 18 years of age
- Presenting with pelvic pain persisting for at least 6 months
- Diagnosed with myofascial syndrome of the pelvic floor muscles (PFM) by a specialist based on physical assessment
- Presenting with pelvic pain intensity greater than 4 on the Visual Analog Scale (VAS) in the last 3 months
- Agreed to sign the informed consent form.
- included the following:
- Patients who were pregnant
- Postpartum patients who had given birth within the last year
- Patients with a history of vulvovaginal pathology
- Contraindications for the use of radiofrequency: metal implants or active infection
- Patients with a history of pelvic cancer, including those who had undergone chemotherapy, radiotherapy, and/or brachytherapy.
The study team makes the final eligibility decision.
Where it's taking place
- Barcelona, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 8 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Barcelona, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.